Tesamorelin – Aliquot, 5mg
Data Sheet
| Application | Stimulates the synthesis and release of endogenous GH, with an increase in level of insulin-like growth factor (IGF-1) |
| CAS | 218949-48-5 |
| Molar Mass | 5136 g/mol |
| Chemical Formula | C221H366N72O67S |
| Amino Acid Sequence | YADAXFXNSYRKVLGQLSARKLLQDXMSRQQGESNQERGARARL |
| Synonyms | Egrifta, Tesamorelin, 218949-48-5, 804475-66-9, TH9507, TH 9507, TH-9507, UNII-MQG94M5EEO,Tesamorelin [USAN:INN], MQG94M5EEO, (3E)-hex-3-enoylsomatoliberin, GTPL6959, DTXSID00583207 |
| Storage | Store at ≤4°C, tightly sealed, away from heat, light and moisture |
| Solubility | Soluble in Water |
| Organoleptic Profile | White Powder in 3mL glass aliquot |
| Composition | Each aliquot contains Tesamorelin |
| Specification | Tesamorelin content (per aliquot): Tesamorelin 5mg ±10% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
GHRH Analogue Peptide for Growth Hormone and Metabolic Research
Tesamorelin is a research-grade synthetic peptide widely studied for its potential relevance in growth hormone-releasing hormone (GHRH) signaling, pituitary-endocrine pathway research, metabolic regulation models, and peptide endocrinology investigations. As a modified GHRH analogue of significant interest in growth factor science, Tesamorelin has attracted scientific attention in studies involving GH/IGF-associated pathways, pulsatile secretion signaling, and metabolic physiology research.
Researchers have investigated Tesamorelin in models involving GHRH receptor-mediated mechanisms, endocrine signaling pathways, growth factor regulation research, and peptide-mediated metabolic studies. Its investigational profile has made it a notable compound in advanced peptide science.
Supplied as a laboratory-grade aliquot for analytical and research applications.
Common Research Areas
- GHRH Signaling Research
- Growth Hormone Axis Studies
- Metabolic Regulation Investigation
- Endocrine and Growth Factor Models
- Peptide Research Applications
How Tesamorelin Works
Tesamorelin has been studied for its potential interaction with pathways associated with GHRH receptor signaling, pituitary regulation, and growth factor biology. Researchers have explored its relevance in models involving GH/IGF-associated mechanisms, metabolic signaling pathways, and peptide-mediated endocrine regulation.
Its modified peptide profile has made it a recurring subject in advanced research science.
Research Overview
Tesamorelin has been investigated across a range of research models involving endocrine biology, growth factor signaling, and metabolic pathways.
Areas of scientific interest include:
- GHRH pathway studies
- Pituitary signaling investigations
- Growth factor research models
- Metabolic regulation studies
- Peptide pathway research
Its broad research relevance continues to make it a notable compound in peptide science.
Tesamorelin vs Related Compounds
Tesamorelin vs Sermorelin
Tesamorelin is often researched as a modified GHRH analogue, while Sermorelin is commonly investigated as a foundational GHRH peptide.
Tesamorelin vs Ipamorelin
Ipamorelin has drawn interest in ghrelin receptor-associated secretagogue research, whereas Tesamorelin is more strongly associated with GHRH receptor signaling investigations.
Frequently Asked Questions
What is Tesamorelin studied for?
It is commonly researched in GHRH signaling, growth hormone pathways, metabolic regulation, and endocrine-associated models.
What type of compound is Tesamorelin?
Tesamorelin is classified as a GHRH analogue research peptide.
How should Tesamorelin be stored?
Lyophilized peptide aliquots are generally stored refrigerated according to laboratory handling protocols.
